Molecules 2012-01-01

Antiplasmodial and leishmanicidal activities of 2-cyano-3-(4-phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives.

Carlos Barea, Adriana Pabón, Silvia Galiano, Silvia Pérez-Silanes, German Gonzalez, Chloe Deyssard, Antonio Monge, Eric Deharo, Ignacio Aldana

Index: Molecules 17(8) , 9451-61, (2012)

Full Text: HTML

Abstract

Malaria and leishmaniasis are two of the World's most important tropical parasitic diseases. Thirteen new 2-cyano-3-(4-phenylpiperazine-1-carboxamido) quinoxaline 1,4-dioxide derivatives (CPCQs) were synthesized and evaluated for their in vitro antimalarial and antileishmanial activity against erythrocytic forms of Plasmodium falciparum and axenic forms of Leishmania infantum. Their toxicity against VERO cells (normal monkey kidney cells) was also assessed. None of the tested compounds was efficient against Plasmodium, but two of them showed good activity against Leishmania. Toxicity on VERO was correlated with leishmanicidal properties.

Related Compounds

  • N,N-Dimethylforma...
  • Triethylammonium c...
  • Triethylamine
  • triethylammonium a...
  • Triethylamine Pho...
  • triethylammonium p...

Related Articles:

Acetyltransferase p300/CBP associated Factor (PCAF) regulates crosstalk-dependent acetylation of histone H3 by distal site recognition.

2015-01-16

[ACS Chem. Biol. 10(1) , 157-64, (2015)]

Development of novel formulations to enhance in vivo transdermal permeation of tocopherol.

2014-09-01

[Acta. Pharm. 64(3) , 299-309, (2014)]

Kuwanon V inhibits proliferation, promotes cell survival and increases neurogenesis of neural stem cells.

2015-01-01

[PLoS ONE 10(2) , e0118188, (2015)]

Differentiation of human umbilical cord matrix mesenchymal stem cells into neural-like progenitor cells and maturation into an oligodendroglial-like lineage.

2014-01-01

[PLoS ONE 9(10) , e111059, (2014)]

Biocompatible, biodegradable and porous liquid crystal elastomer scaffolds for spatial cell cultures.

2015-02-01

[Macromol. Biosci. 15(2) , 200-14, (2015)]

More Articles...